BIOESSAYS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1231996, encodeId=11a112319968f, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：投的综述（非约稿），一个多月就给了审稿意见：大修，2个审稿人给了20来个意见吧，给了3个月时间修回。然后小修，半个月内修回，直接接收了，速度还是很快的，给的建议也很中肯，大修修回后，编辑还帮忙改了下，编辑真的大好人啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42c95627019, createdName=ms8000001392202468, createdTime=Tue Jul 12 14:39:08 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087882, encodeId=778f108e88212, content=我能直接投nature/science这种顶级杂志吗？它们会反馈意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087881, encodeId=399f108e8816a, content=每个期刊梯度一般情况下选择几个备选期刊合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543971, encodeId=1ed15439e181, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2022-07-12 ms8000001392202468

审稿速度:2.0 | 投稿命中率:50.0
经验分享：投的综述（非约稿），一个多月就给了审稿意见：大修，2个审稿人给了20来个意见吧，给了3个月时间修回。然后小修，半个月内修回，直接接收了，速度还是很快的，给的建议也很中肯，大修修回后，编辑还帮忙改了下，编辑真的大好人啊。

62 0

[GetPortalCommentsPageByObjectIdResponse(id=1231996, encodeId=11a112319968f, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：投的综述（非约稿），一个多月就给了审稿意见：大修，2个审稿人给了20来个意见吧，给了3个月时间修回。然后小修，半个月内修回，直接接收了，速度还是很快的，给的建议也很中肯，大修修回后，编辑还帮忙改了下，编辑真的大好人啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42c95627019, createdName=ms8000001392202468, createdTime=Tue Jul 12 14:39:08 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087882, encodeId=778f108e88212, content=我能直接投nature/science这种顶级杂志吗？它们会反馈意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087881, encodeId=399f108e8816a, content=每个期刊梯度一般情况下选择几个备选期刊合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543971, encodeId=1ed15439e181, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2021-12-29 msSSSSSD

我能直接投nature/science这种顶级杂志吗？它们会反馈意见吗？

60 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1231996, encodeId=11a112319968f, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：投的综述（非约稿），一个多月就给了审稿意见：大修，2个审稿人给了20来个意见吧，给了3个月时间修回。然后小修，半个月内修回，直接接收了，速度还是很快的，给的建议也很中肯，大修修回后，编辑还帮忙改了下，编辑真的大好人啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42c95627019, createdName=ms8000001392202468, createdTime=Tue Jul 12 14:39:08 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087882, encodeId=778f108e88212, content=我能直接投nature/science这种顶级杂志吗？它们会反馈意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087881, encodeId=399f108e8816a, content=每个期刊梯度一般情况下选择几个备选期刊合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543971, encodeId=1ed15439e181, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2021-12-28 ms6000000264964247

每个期刊梯度一般情况下选择几个备选期刊合适？

68 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1231996, encodeId=11a112319968f, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：投的综述（非约稿），一个多月就给了审稿意见：大修，2个审稿人给了20来个意见吧，给了3个月时间修回。然后小修，半个月内修回，直接接收了，速度还是很快的，给的建议也很中肯，大修修回后，编辑还帮忙改了下，编辑真的大好人啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42c95627019, createdName=ms8000001392202468, createdTime=Tue Jul 12 14:39:08 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087882, encodeId=778f108e88212, content=我能直接投nature/science这种顶级杂志吗？它们会反馈意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087881, encodeId=399f108e8816a, content=每个期刊梯度一般情况下选择几个备选期刊合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543971, encodeId=1ed15439e181, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2017-07-16 wang_di98

徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了

340 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务